Previous Article | Next Article ![]()
Journal of Virology, October 2001, p. 9427-9434, Vol. 75, No. 19
Department of Molecular Genetics and
Microbiology, Center for Mammalian Genetics, and University of Florida
Shands Cancer Center, University of Florida College of Medicine,
Gainesville, Florida 326101; Department
of Laboratory Medicine, Comprehensive Cancer Center, University of
California
Received 29 March 2001/Accepted 19 June 2001
Juvenile myelomonocytic leukemia (JMML) is a disease that occurs in
young children and is associated with a high mortality rate. In most
patients, JMML has a progressive course leading to death by virtue of
infection, bleeding, or progression to acute myeloid leukemia (AML). As
it is known that children with neurofibromatosis type 1 syndrome have a
markedly increased risk of developing JMML, we have previously
developed a mouse model of JMML through reconstitution of lethally
irradiated mice with hematopoietic stem cells homozygous for a
loss-of-function mutation in the Nf1 gene (D. L. Largaespada, C. I. Brannan, N. A. Jenkins, and N. G. Copeland, Nat. Genet. 12:137-143, 1996). In the course of
these experiments, we found that all these genetically identical
reconstituted mice developed a JMML-like disorder, but only a subset
went on to develop more acute disease. This result strongly suggests
that additional genetic lesions are responsible for disease progression
to AML. Here, we describe the production of a unique tumor panel,
created using the BXH-2 genetic background, for identification of these
additional genetic lesions. Using this tumor panel, we have identified
a locus, Epi1, which maps 30 to 40 kb downstream of the
Myb gene and appears to be the most common site of somatic
viral integration in BXH-2 mice. Our findings suggest that proviral
integrations at Epi1 cooperate with loss of Nf1
to cause AML.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.9427-9434.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Retroviral Integration at the Epi1
Locus Cooperates with Nf1 Gene Loss in the
Progression to Acute Myeloid Leukemia
San Francisco, San Francisco, California
941432; Mouse Cancer Genetics Program,
National Cancer Institute
Frederick, Frederick, Maryland
217023; and Department of Genetics, Cell
Biology and Development, University of Minnesota Cancer Center,
Minneapolis, Minnesota 554554
*
Corresponding author. Mailing address: Department of
Molecular Genetics and Microbiology, P.O. Box 100266, University of
Florida College of Medicine, Gainesville, FL 32610. Phone: (352)
392-3296. Fax: (352) 392-3133. E-mail:
brannan{at}mgm.ufl.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»